Just as a skilled pharmacist meticulously tailors each prescription to achieve the perfect therapeutic outcome, ProxsysRx fine-tunes a 340B savings strategy to deliver optimal results. With over $500 million in 340B revenue generated for hospitals, the ProxsysRx system ensures enhanced revenue and complete compliance.
With the ProxsysRx program support and proprietary software, pharmacies can streamline 340B management and unlock its full ROI potential. The proprietary software examines records to identify and automatically apply for both current and past 340B-eligible prescriptions. Moreover, the pharmacy will always receive an up-to-date database of 340B-eligible drugs to ensure compliance, while detailed electronic records provide instant evidence to counter any non-compliance claims.
If your hospital is 340B-eligible, you might be missing out on substantial savings. For instance, a single Humira refill could cost up to $1,200 more if not processed through 340B. Make sure you’re maximizing your potential savings for the pharmacy and patients.
